Navigation Links
The Quantum Group Announces Resource Reallocation to Advance PWeR(TM) Platform
Date:3/25/2009

WELLINGTON, Fla., March 25 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (NYSE Amex: QGP) (www.QuantumMD.com) announced it has implemented a reallocation of people and resources from other Company operations to advance the PWeR(TM) (pronounced POWER) platform. As Quantum continues to set the foundation for the explosive growth potential the Company expects for the PWeR platform, it has shifted its structure to allow for this growth.

PWeR (Personal Wellness electronic Record) is the healthcare information technology platform developed and deployed by the Company. PWeR meets and exceeds the guidelines set forth from Washington to implement electronic health records, and the platform is currently being utilized by more than 75 providers since the Fall of 2008.

The most significant aspect of the reallocation was a tactical move to create a very experienced and well-trained PWeR sales team with established provider relationships. There have been early indications of eager acceptance of PWeR from the industry. To achieve this objective, several Provider Specialists from Quantum subsidiary company Renaissance Health Systems have been transitioned to PWeR Team Specialists.

"The implementation of technology to address the lack of interconnectivity and communication in the healthcare industry has been a principle mission of our Company since inception. PWeR is patient-centric and combines all of the features and applications needed by payers, healthcare providers and hospitals into one dynamic system," said Noel J. Guillama President of The Quantum Group. He further commented, "PWeR is an IBM hosted solution that is web-based and designed to address the privacy, security and scalability necessary for national and global deployment. PWeR is low cost, easy to implement and offers a 360 degree view of a patient record. The industry is beginning to transform as a result of a federal mandate to reduce costs, increase efficiencies and improve the quality of patient care. We are excited by the possibilities ahead with PWeR."

The Stimulus Package (American Recovery and Reinvestment Act of 2009) has designated $19.2 billion to promote and expand the use of technology in the U.S. healthcare industry to improve the quality of patient care and reduce costs.

Ronald S. Smith, Senior Vice President and Chief Development Officer, has been charged with leading the new team of PWeR Specialists. Smith commented, "The new PWeR Team Specialists have personally established relationships with many of the 2,000 plus providers currently affiliated with Renaissance. They will now be able to expand their reach into larger geographical areas as they work hand in hand with their Renaissance Provider Specialist counterparts and co-market the Renaissance opportunity. This is a natural progression that we believe will yield great results for both Renaissance and PWeR. We have also adjusted support personnel at every level of the organization to provide the support services that PWeR will require for an effective industry deployment."

Guillama held a conference with employees of The Quantum Group to explain the reallocation and to elaborate on the business plans for PWeR. He noted that the Quantum team is comprised of the most talented, dedicated and innovative people he has had the pleasure of working alongside. Guillama noted that the Company-wide efforts used to establish Renaissance have provided the footprint for the new emphasis on PWeR. "Renaissance is performing as it was designed to do and has formed the foundation of our Company. Now we are continuing to build as we turn our emphasis toward establishing PWeR. We expect Renaissance to continue growing and serving the approximately 2,000 affiliated providers and multiple payers we have contracted."

The Company expects to provide financial projections on potential sales and expansion in the coming months as preliminary results are accessed.

About The Quantum Group, Inc.

The Quantum Group is an innovation-driven Healthcare Services Organization (HSO) that provides business process solutions, service chain management, strategic consulting and leading edge technology to the healthcare industry.

Quantum has developed and deployed PWeR(TM), a cutting-edge, patent-pending healthcare technology platform that has been designed to bridge the gaps of communication and exchange of patient information throughout the healthcare industry. PWeR can integrate all of the functions a physician/provider, hospital, clinic and related professionals utilize in one patient-centric, web-based platform and falls well within the economic incentives offered by the new $19 billion Stimulus Package for healthcare information technology. We believe we are positioned to be a catalyst for change as we take aim at the $700 billion inefficiency gap in the United States healthcare industry.

About PWeR (Personal Wellness electronic Record)

For more information visit www.myPWeR.com.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8, SB-2, S-1 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" "could" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to continue revenue growth trend in fiscal year 2009, to control patient medical cost relative to income received, to attract and retain executive, management and operational personnel, to continue growing its patient base, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well as physician clients. We have further risk in the deployment of our technology platform, the utilization by our clients, technical and software setbacks, cost of development, as well as the capital to deploy it. We are subject further to interruptions of service. Company does not undertake any obligation to publicly update any forward-looking statements. As a result, investors should not place undue reliance on these forward-looking statements.

                       FOR MORE INFORMATION, PLEASE CONTACT:
                                 Red Chip Companies
                             Dave Gentry: 407-644-4256
                                 dave@redchip.com
                                        or
                              PR Financial Marketing
                            Jim Blackman: 713-256-0369
                                jim@prfmonline.com
                                        or
                              The Quantum Group, Inc.
                          Danielle Amodio:  561.798.9800
                              DAmodio@QuantumMD.com


'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Quantum light beams good for fast technology
2. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
3. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
4. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
5. Results promising for computational quantum chemical methods for drug development
6. The Quantum Group, Inc. Announces Separation of Units
7. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
8. The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th
9. The Quantum Group Announces Strategic Technology Alliance
10. The Quantum Group Announces 1st Quarter Financial Results for Fiscal Year 2008
11. The Quantum Group Extends CEOs Employment Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 23, 2017 , ... Old School Labs™, makers of the wildly popular all-natural ... Breon Ansley to its growing team of brand ambassadors. The Olympia top finisher and ... less than a year was able to turn professional, participating in the 2013 NPC ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... online education programs and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources to assist in ... seafood-rich diet. These resources have been developed for use by nutrition educators ...
(Date:1/22/2017)... Boca Raton, FL (PRWEB) , ... January 22, 2017 , ... ... products to customers across the world, recently met with big-name retail buyers at the ... strong scientific evidence of efficacy and uses the utmost safety standards in all of ...
(Date:1/21/2017)... ... ... perfect set of tools for video editors that want to create the illusion of rack ... of Pixel Film Studios. , Video editors using ProDOF can add realistic depth of ... from one area into the next. ProDOF comes with 0.5 second, 1.0 second, 1.5 ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... of its new medical office in Petaluma, located at 167 Lynch Creek Way. ... access to SRO sports medicine and rehabilitation services and on-site x-ray ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... , January 23, 2017 A new Transparency ... Market was valued at US$0.53 bn in 2013 and is ... strong 17.50% CAGR between 2014 and 2022. The title of the ... Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022." ... Non-invasive prenatal testing (NIPT), ...
(Date:1/23/2017)... DIEGO and PALMA, Spain ... Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company ... that the first patient has been enrolled in ... lead candidate, SNF472, for the treatment of cardiovascular ... (HD). Most ESRD patients, in the ...
(Date:1/21/2017)... Research and Markets has announced the addition of the ... (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, ... HIV/AIDS etc.), Forecast to 2022" report to their offering. ... US ... clinical lab testing, which has evolved as a major source ...
Breaking Medicine Technology: